Drug recall · February 12, 2014
Glipizide XL recall
Why: Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2
- Lots / codes
lot V112000, EXP Jun 2016
- Quantity
- 22,529 bottles
- Company
- Greenstone Llc, Peapack, NJ
- Distribution
- US Nationwide (including PR)
- Initiated
- November 4, 2013 · Voluntary: Firm initiated
- Classified
- February 3, 2014
- Reported
- February 12, 2014
- Ended
- June 24, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glipizide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.